PuSH - Publication Server of Helmholtz Zentrum München

Dürauer, S.* ; Kang, H.-S. ; Wiebeler, C.* ; Machida, Y.* ; Schnapka, D.S.* ; Yaneva, D.* ; Renz, C.* ; Götz, M.J.* ; Weickert, P.* ; Major, A.C.* ; Rahmanto, A.S.* ; Gutenthaler-Tietze, S.M.* ; Daumann, L.J.* ; Beli, P.* ; Ulrich, H.D.* ; Sattler, M. ; Machida, Y.J.* ; Schwierz, N.* ; Stingele, J.*

Allosteric activation of the SPRTN protease by ubiquitin maintains genome stability.

Nat. Commun. 16:5422 (2025)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The DNA-dependent protease SPRTN maintains genome stability by degrading toxic DNA-protein crosslinks (DPCs). To understand how SPRTN's promiscuous protease activity is confined to cleavage of crosslinked proteins, we reconstitute the repair of DPCs including their modification with SUMO and ubiquitin chains in vitro. We discover that DPC ubiquitylation strongly activates SPRTN independently of SPRTN's known ubiquitin-binding domains. Using protein structure prediction, MD simulations and NMR spectroscopy we reveal that ubiquitin binds to SPRTN's protease domain, promoting an open, active conformation. Replacing key interfacial residues prevents allosteric activation of SPRTN by ubiquitin, leading to genomic instability and cell cycle defects in cells expressing truncated SPRTN variants that cause premature aging and liver cancer in Ruijs-Aalfs syndrome patients. Collectively, our results reveal a ubiquitin-dependent regulatory mechanism that ensures SPRTN activity is deployed precisely when and where it is needed.
Impact Factor
Scopus SNIP
Altmetric
15.700
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2025
HGF-reported in Year 2025
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Quellenangaben Volume: 16, Issue: 1, Pages: , Article Number: 5422 Supplement: ,
Publisher Nature Publishing Group
Publishing Place London
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-503000-001
Scopus ID 105011192542
PubMed ID 40691134
Erfassungsdatum 2025-07-23